If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, ...
4d
Medpage Today on MSNSubstantial Variation Seen in Ileosigmoid Fistula Management in Crohn’s DiseaseORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...
Pythons may hold the answer to another way to regrow our guts, a group of researchers led by the University of Texas at ...
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...
A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...
Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring ...
Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...
2d
Zacks.com on MSNEMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's DiseaseThe CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn's disease patients with or ...
Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s diseasePrimary endpoints met in ...
Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results